It is FDA-approved for adults with type 2 diabetes, but it may also be prescribed off-label for weight management when a medical provider determines that it is appropriate
Other contributing factors include cardiovascular disease, obesity, polypharmacy, and psychological factors, all of which are common in patients prescribed tirzepatide
Uptake has been strongest among working males aged 40-60 in metropolitan regions
Gadde KM, Franciscy DM, Wagner HR, Krishnan KR
BreezeMeds Reviewed: 2026 Consumer Report on Breeze Meds GLP-1 Telehealth - Semaglutide From $199, Four Named Pharmacies, and What the FDA's June 29 Deadline Means for New Patients An independent advertorial overview of the Breeze Meds compounded GLP-1 and NAD+ telehealth programs, FSA/HSA eligibility, all-50-state availability, four licensed 503A compounding pharmacy partners, and the April 30, 2026 FDA 503B exclusion proposal every prospective enrollee should understand before committing
The absolute risk of probable dementia for CE plus MPA versus placebo was 45 versus 22 cases per 10,000 women-years8 [see Use in Specific Populations (8.5), and Clinical Studies (14.4)]
